The aim of this conference is to provide a critical review and analysis of the best available tools for the assessment of disease severity and progression in different stages of fibrogenic chronic liver diseases. To reach this aim, an international panel of key experts and participants from all around the world will actively interact to resolve pending issues and to highlight areas needing further analysis and investigation.